What's New

Lorlatinib (Lorbrena®)

Lorlatinib (Lorbrena®) is a tyrosine kinase inhibitor (TKI) used in the treatment of progressive, metastatic non small cell lung cancer.

Talazoparib (Talzenna™)

Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer. 

Cemiplimab-rwlc (Libtayo®)

Cemiplimab-rwlc (Libtayo®) is a monoclonal antibody used in the treatment of some cases of squamous cell cancer of the skin. 


OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

Dear Caregivers, We See You and We Thank You.
by Karen Arnold-Korzeniowski, BSN, RN
Nov 16, 2018

At the Junction of Bitter and Sweet
by OncoLink Team
Nov 14, 2018

Patient Education by the Numbers: Part I
by OncoLink Team
Nov 12, 2018

View all Blogs

The Great American Smokeout is a Step Towards Becoming Smoke Free!

Each year, on the 3rd Thursday of November, The American Cancer Society marks the Great American Smokeout by encouraging smokers to use the date to make a plan to quit, or to plan in advance and quit smoking that day.  To help you in your quest to be smoke free, access our quit smoking resources or learn about the benefits of quitting smoking - even after a cancer diagnosis.

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.